Immune-related adverse events from combination immunotherapy in cancer patients: A comprehensive meta-analysis of randomized controlled trials

Although available evidence from clinical trials has shown that immune checkpoint inhibitors (ICIs) combination therapy can lead to a series of immune-related adverse events (irAEs), the overall risk of irAEs on combination therapy has yet not been systematically reported. Therefore, we performed a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International immunopharmacology 2018-10, Vol.63, p.292-298
Hauptverfasser:	Zhang, Bo, Wu, Qiong, Zhou, You Lang, Guo, Xinyu, Ge, Jun, Fu, Jiaji
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Antineoplastic Agents, Immunological - adverse effects Antineoplastic Combined Chemotherapy Protocols - adverse effects Cancer Cancer therapies Clinical trials Colitis Combination immunotherapy Complications Diarrhea Humans Hyperthyroidism Hypothyroidism Immune checkpoint inhibitor Immune checkpoint inhibitors Immune system Immunotherapy Medical research Meta-analysis Neoplasms - drug therapy Neoplasms - immunology Patients Pneumonitis Randomization Randomized Controlled Trials as Topic Risk analysis Scientific papers Search engines Side effects Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!